Zivo Bioscience Inc (ZIVO) USD0.001

Sell:$13.50Buy:$13.50$0.99 (7.91%)

Prices delayed by at least 15 minutes
Sell:$13.50
Buy:$13.50
Change:$0.99 (7.91%)
Prices delayed by at least 15 minutes
Sell:$13.50
Buy:$13.50
Change:$0.99 (7.91%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 October 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
1,659$12.05$19,990.95575,095
8 October 2025
Christopher D MaggioreIndependent Director
Buy
Regular purchase transaction
23,682$12.01$284,420.82517,526
30 September 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
15,322$15.99$244,998.78573,436
13 June 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
3,488$14.33$49,983.04558,114
8 April 2025
Christopher D MaggioreIndependent Director
Sell
Regular sell transaction (market)
20$16.25$325.00507,000
26 December 2024
STROME GROUP INCInvestment Management Company
Buy
Regular purchase transaction
75,000$20.19$1,514,250.00398,683

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 December 2024
STROME GROUP INCInvestment Management Company
Buy
Regular purchase transaction
75,000$20.19$1,514,250.00398,683
8 October 2025
Christopher D MaggioreIndependent Director
Buy
Regular purchase transaction
23,682$12.01$284,420.82517,526
30 September 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
15,322$15.99$244,998.78573,436
13 June 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
3,488$14.33$49,983.04558,114
10 October 2025
HEP INVESTMENTS LLCPrivate Equity
Buy
Regular purchase transaction
1,659$12.05$19,990.95575,095

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.